SPONSORED:

Grassley to hold drug pricing hearing

Grassley to hold drug pricing hearing
© Stefani Reynolds

The Senate Finance Committee's first hearing of the year will focus on prescription drug prices, panel chairman Sen. Chuck GrassleyChuck GrassleyGrassley to vote against Tanden nomination Grassley says he'll decide this fall whether to run in 2022 Yellen deputy Adeyemo on track for quick confirmation MORE (R-Iowa) announced Tuesday.

The Jan. 29 hearing "will be the first in a series of hearings scrutinizing prescription drug pricing and considering policy and oversight solutions to lower costs for American patients," Grassley said in a statement Tuesday.

"We already know what the problem is. It’s time to look at bipartisan solutions and work to turn them into law,” he added.

The Senate hearing will be the same day the Democratic-led House Oversight and Reform Committee holds the first of its own drug pricing hearings.

ADVERTISEMENT

The two hearings on the same day shows the bipartisan nature of the concern over rising drug prices.

Grassley and House Oversight and Reform Committee Chairman Elijah CummingsElijah Eugene CummingsHouse Democrats reintroduce bill to reduce lobbyist influence Trump voters and progressives have a lot in common — and Biden can unite them We must act on lowering cost of prescription drugs MORE (D-Md.) have made rising drug prices a central concern.

Grassley is largely seen as a dogged investigator who backs free-market principles, and is not seen as an ally of the pharmaceutical industry.

He is also willing to work with Democrats. In September he teamed up with Sen. Dick DurbinDick DurbinMurkowski undecided on Tanden as nomination in limbo Democrats ask FBI for plans to address domestic extremism following Capitol attack Progressive support builds for expanding lower courts MORE (D-Ill.) to legislate that television advertisements for drugs be accompanied by price disclosures. The measure was ultimately blocked by House Republicans.

Earlier this month, Grassley laid out his priorities for drug pricing action, including legislation with Sen. Amy KlobucharAmy KlobucharOpen-ended antitrust is an innovation killer FBI, DHS and Pentagon officials to testify on Capitol riot Five big takeaways on the Capitol security hearings MORE (D-Minn.) that would allow patients to import prescription drugs from Canada.

He has also expressed support for much of President TrumpDonald TrumpDonald Trump Jr. calls Bruce Springsteen's dropped charges 'liberal privilege' Schiff sees challenges for intel committee, community in Trump's shadow McConnell says he'd back Trump as 2024 GOP nominee MORE's drug pricing agenda.